摘要
非小细胞肺癌为最常见恶性肿瘤,传统治疗尤其是手术治疗仍是最佳方法,但是能够施行手术的患者比例很小,而且手术后发生复发和转移的比例很高,因此综合治疗方法治疗非小细胞肺癌是近年来治疗发展的方向,尤其是分子靶点药物的开发应用及多学科治疗模式的发展,非小细胞肺癌的治疗疗效有了提高。
Non-small cell lung carcinoms is the most cowanon malignant tumour. Traditional therapy, especially surgery is still the most effective treatment, but the portion of patients suitable for surgery is very small. More seriously, both Postoperative relapse rate and metastasis rate is still very high. So its combined therapy is becoming a predominant treatment in recent years, especially the application and exploitation of molecular targeted drugs and the development of multiple ssubject therapeutic mode, which bring great increased therapeutic efficacy to non-small cell lung.
出处
《医学综述》
2007年第9期690-692,共3页
Medical Recapitulate
